• 1
    Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer. 1997; 33: 10251030.
  • 2
    Loprinzi CL, Laurie JA, Wieand HS, et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol. 1994; 12: 601607.
  • 3
    Sloan JA, Loprinzi CL, Laurine JA, et al. A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol. 2001; 19: 35393546.
  • 4
    Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol. 2002; 20: 25142519.
  • 5
    Coates AS, Gebski V, Bishop JF, et al. Improving the quality of life in advanced breast cancer. A comparison of continuous and intermittent strategies. N Engl J Med. 1987; 317: 14901495.
  • 6
    Coates AS, Byrne M, Bishop JF, et al. Intermittent versus continuous chemotherapy for breast cancer [letter]. N Engl J Med. 1988; 318: 1468.
  • 7
    Coates AS, Gebski V, Signorini D, et al. Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. Australian-New Zealand Breast Cancer Trials Group. J Clin Oncol. 1992; 10: 18331838.
  • 8
    Butow PN, Coates AS, Dunn SM. Psychosocial predictor of survival: metastatic breast cancer. Ann Oncol. 2000; 11: 469474.
  • 9
    Shimozuma K, Sonoo H, Ichihara K, et al. The prognostic value of quality of life scores: preliminary results of an analysis of patients with breast cancer. Surg Today. 2000; 30: 255261.
  • 10
    Coates AS, Hurny C, Peterson HF, et al. Quality-of-life scores predict outcome in metastatic but not early breast cancer. J Clin Oncol. 2000; 18: 37683774.
  • 11
    Blazeby JM, Brookes ST, Alderson D. The prognostic value of quality of life scores during treatment for oesophageal cancer. Gut. 2001; 49: 227230.
  • 12
    Earlam S, Glover C, Fordy C, et al. Relation between tumor size, quality of life and survival in patients with colorectal liver metastases. J Clin Oncol. 1996: 14: 171175.
  • 13
    Coates AS, Thomson D, McLeod GR, et al. Prognostic value of quality of life score in trial of chemotherapy with or without interferon in patients with metastatic melanoma. Eur J Cancer. 1993; 29A: 17311734.
  • 14
    Butow PN, Coates AS, Dunn SM. Psychosocial predictors of survival in metastatic melanoma. J Clin Oncol. 1999; 17: 22562263.
  • 15
    Kaasa S, Mastekaasa A, Lund E. Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease: the importance of patients' subjective experience of disease and psychosocial well-being. Radiol Oncol. 1989; 15: 235242.
  • 16
    Ruckdeschel JC, Piantadosi S, The Lung Cancer Study Group. Quality of life assessments in lung surgery for brochogenic carcinoma. Theor Surg. 1991; 6: 201205.
  • 17
    Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer. 1991; 67: 31313135.
  • 18
    Buccheri GF, Ferrigno D, Tamburini M, Brunelli C. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer. 1995; 12: 4558.
  • 19
    Herndon JE II, Fleishman S, Kornblith AB, et al. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer. 1999; 85: 333340.
  • 20
    Montazeri A, Milroy R, Hole D, et al. Quality of life in lung cancer patients: an important prognostic factor. Lung Cancer. 2001; 31: 233240.
  • 21
    Tamburini M, Brunelli C, Rosso S, Ventafridda V. Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage. 1996; 1: 3241.
  • 22
    Maltoni M, Pirovano M, Nanni O, et al. Prognostic factors in terminal cancer patients. Eur J Palliat Care. 1996; 3: 122125.
  • 23
    Viganò A, Dorgan M, Bruera E, Buckingam J, Suarez-Almazor ME. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med. 2000; 14: 363374.
  • 24
    Cassileth BR, Lusk EJ, Miller DS, et al. Psychosocial correlates of survival in advanced malignant disease? N Engl J Med. 1985; 312: 15511555.
  • 25
    Cassileth BR, Walsh WP, Lusk EJ. Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol. 1988; 6: 17531759.
  • 26
    Ringdal GI, Ringdal K, Kvinnsland S, Gotestam KG. Quality of life of cancer patients with different prognoses. Qual Life Res. 1994; 3: 143154.
  • 27
    Ringdal GI, Gotestam KG, Kaasa S, et al. Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer. 1996; 73: 15941599.
  • 28
    Ringdal GI, Ringdal K. A follow-up study of the quality of life in cancer patients with different prognoses. Qual Life Res. 2000; 9: 6573.
  • 29
    Addington-Hall JM, MacDonald LD, Anderson HR. Can the Spitzer's Quality of Life Index help to reduce prognostic uncertainty in terminal care? Br J Cancer. 1990; 62: 695699.
  • 30
    Dancey J, Zee B, Osoba D, et al. Quality of life scores: an independent prognostic variable in a general population of cancer patient receiving chemotherapy. Qual Life Res. 1997; 6: 151158.
  • 31
    Chang VT, Thaler H, Polyak TA, et al. Quality of life and survival. Cancer. 1998; 83: 173179.
  • 32
    Laupacis A, Wells G, Richardson WS, et al. Users' guides to medical literature, V. How to use an article about prognosis. JAMA. 1994; 272: 234237.
  • 33
    Roud PC. Psychosocial variables associated with the exceptional survival of patients with advanced malignant disease. Int J Psychiatr Med. 1986/1987; 16: 113122.
  • 34
    Watson M, Haviland JS, Greer S, et al. Influence of psychological response on survival in breast cancer; a population cohort study. Lancet. 1999; 354: 13311336.
  • 35
    Hodgson C, Higginson IJ, McDonnell M, Butters E. Family anxiety in advanced cancer: a multicentre prospective study in Ireland. Br J Cancer. 1997; 76: 12111214.
  • 36
    Edmonds P, Higginson I, Altmann D, Sen-Gupta G, McDonnell M. Is the presence of dyspnea a risk factor for morbidity in cancer patients? J Pain Symptom Manage. 2000; 19: 1522.
  • 37
    Higginson IJ, Costantini M. Communication in end-of-life cancer care: a comparison of team assessments in three European countries. J Clin Oncol. 2002; 20: 36743682.
  • 38
    Viganò A, Bruera E, Suarez-Almazor ME. Terminal cancer syndrome: myth or reality. J Palliat Care. 1999; 15: 3239.
  • 39
    Karfnosky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeodCM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1949: 199205.
  • 40
    Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993; 85: 365376.
  • 41
    Higginson I, McCarthy MA. comparison of two measures of quality of life: their sensitivity and validity for patients with advanced cancer. Palliat Med. 1994; 8: 282290.
  • 42
    Higginson I, McCarthy M. Validity of the Support Team Assessment Schedule: views of patients and families. Palliat Med. 1993; 7: 219228.
  • 43
    Parmar MKB, Machin D. Survival analysis: a practical approach. Chichester: John Wiley & Sons, 1994.
  • 44
    SPSS Inc. SPSS for Windows. Base system user's guide, release 8.0. Chicago: SPSS, Inc, 1998.
  • 45
    Viganò A, Bruera E, Jhangri GS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000; 160: 861868.
  • 46
    Perreira J, Bruera E. Chronic nausea. In: BrueraE, HigginsonIJ, editors. Cachexia-anorexia in cancer patients. Oxford: Oxford University Press, 1996.
  • 47
    Bruera E, Chadwick S, MacDonald N, et al. Study of cardiovascular autonomic insufficiency in advanced cancer patients. Cancer Treat Rep. 1986; 70: 13831387.
  • 48
    Bruera E, Strasser F. Anorexia-cachexia. In: BrueraE, RipamontiC, editors. Gastrointestinal symptoms in advanced cancer patients. Oxford: Oxford University Press, 2002: 3980.
  • 49
    Viganò A, Watanabe S, Bruera E. Anorexia and cachexia in advanced cancer patients. Cancer Surveys. 1994; 21: 99115.
  • 50
    Krech RL, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage. 1991; 6: 360367.
  • 51
    Ripamonti C, Bruera E. Dyspnea: pathophysiology and assessment. J Pain Symptom Manage. 1997; 13: 220232.
  • 52
    Reuben DB, Mor V, Hiris J, et al. Clinical symptoms of survival in patients with terminal cancer. Arch Intern Med. 1988; 148: 15861591.
  • 53
    Bruera E, Miller MJ, Kuehn N, et al. Estimated survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage. 1992; 7: 8286.
  • 54
    Allard P, Dionne A, Potvin D. Factors associated with length of survival among 1081 terminally ill cancer patients. J Palliat Care. 1995; 11: 2024.
  • 55
    Slevin MI, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988; 57: 109112.
  • 56
    Maguire P. Monitoring the quality of life in cancer patients and their relatives. In: SymingtonT, WilliamsAE, McVieJG, editors. Cancer: assessment and monitoring. London: Churchill Livingstone, 1980: 4052.
  • 57
    Viganò A, Atkinson M, Radice D, et al. Symptom assessment in terminally ill cancer patients: clinical and research insights from the Edmonton Symptom Assessment System (ESAS). Second Congress of the European Association for Palliative Care Research Network, Lyon, France, May 23–25, 2002.
  • 58
    Allison PJ, Guichard C, Fung K, Gilain L. Dispositional optimism predicts survival status 1 year after diagnosis in head and neck cancer. J Clin Oncol. 2003; 21: 543548.
  • 59
    Schofield P, Ball D, Smith J, Borland R, et al. Optimism and survival in lung carcinoma patients. Cancer. 2004; 100: 12761282.
  • 60
    Viganò A, Bruera E. Enteral and parenteral nutrition in cancer patients. In: HigginsonI, BrueraE, editors. Cachexia-anorexia syndrome in advanced cancer. London: Oxford Medical Publications, 1996: 110127.